Edition:
United States

People: Smiths Group PLC (SMIN.L)

SMIN.L on London Stock Exchange

1,422.00GBp
1 Dec 2016
Change (% chg)

11.00p (+0.78%)
Prev Close
1,411.00p
Open
1,409.00p
Day's High
1,436.00p
Day's Low
1,404.00p
Volume
897,219
Avg. Vol
1,507,808
52-wk High
1,543.00p
52-wk Low
858.00p

Angelici, Bruno 

Mr. Bruno F. J. Angelici is Non-Executive Independent Director of Smiths Group Plc. He holda an MBA (Kellogg School of Management) and Business and Law degrees from Reims. Bruno was appointed to the Board in July 2010. Bruno’s career includes senior management roles in pharmaceutical and medical device companies. Bruno retired from AstraZeneca in 2010 as Executive Vice President, International after a 20-year career. He was responsible for Europe, Japan, Asia Pacific, Latin America, Middle East and Africa and originally joined as President of ICI Pharma France. Prior to this, he was at Baxter, a US-based global supplier of medical devices. He has extensive international experience, including in the US, and brings a deep understanding to the Group of the medical device and pharmaceutical industries.

Basic Compensation

Total Annual Compensation, GBP 74,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 74,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --